khondrion.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: | ||
Meta Tags
| Title | Home - |
| Description | bringing energy to Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 87.239.8.169 |
| Location | Netherlands |
Related Websites
| Site | Rank |
More to Explore
khondrion.com Valuation
|
US$1,651,248
Last updated: 2023-05-13 20:47:50
khondrion.com has Semrush global rank of 6,409,884. khondrion.com has an estimated worth of US$ 1,651,248, based on its estimated Ads revenue. khondrion.com receives approximately 190,529 unique visitors each day. Its web server is located in Netherlands, with IP address 87.239.8.169. According to SiteAdvisor, khondrion.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,651,248 |
| Daily Ads Revenue | US$1,525 |
| Monthly Ads Revenue | US$45,727 |
| Yearly Ads Revenue | US$548,723 |
| Daily Unique Visitors | 12,702 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| khondrion.com. | A | 297 | IP: 87.239.8.169 |
| khondrion.com. | NS | 597 | NS Record: nsauth.myrootnet.nl. |
| khondrion.com. | NS | 597 | NS Record: nsauth.myrootnet.com. |
| khondrion.com. | MX | 300 | MX Record: 10 mailfilter01.myrootnet.nl. |
| khondrion.com. | MX | 300 | MX Record: 20 mailfilter02.myrootnet.nl. |
| khondrion.com. | TXT | 300 | TXT Record: v=spf1 a mx ip4:185.173.20.10 ip6:2a0b:3100::10 -all |
HtmlToTextCheckTime:2023-05-13 20:47:50
| About us Our Science Our Focus For Patients & Families Working with others News Contact Select Page bringing energy to life Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease. khondrion Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease. Based on proprietary science and a deep understanding of mitochondrial dysfunction, the company is advancing its wholly owned lead drug candidate sonlicromanol for the treatment of both children and adults. learn more Khondrion joins the NADIS International Student Training Network Khondrion has joined a recently established consortium of universities and industry partners to train international... read more 2022 – A Year in Review 2022 – A Year in Review As 2022 draws to a close, Khondrion’s CEO Jan Smeitink reflects on the significant... read more Khondrion announces sonlicromanol Phase IIb progress |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 22 Dec 2021 02:44:26 GMT X-Powered-By: PHP/7.0.4 X-Redirect-By: WordPress Location: https://www.khondrion.com/ Vary: Accept-Encoding,User-Agent X-Server: w6.cl1.intention.nl Content-Type: text/html; charset=UTF-8 Server: INT/No-Cache X-Varnish: 14303774 Age: 0 Via: 1.1 varnish-v4 grace: none Connection: keep-alive |
khondrion.com Whois Information
Domain Name: KHONDRION.COM Registry Domain ID: 840634019_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2021-02-27T08:20:50Z Creation Date: 2007-02-26T13:48:54Z Registry Expiry Date: 2022-02-26T13:48:54Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: ok https://icann.org/epp#ok Name Server: NSAUTH.MYROOTNET.COM Name Server: NSAUTH.MYROOTNET.NL DNSSEC: signedDelegation DNSSEC DS Data: 13953 13 1 3D7B3943047BACCC731B2293C9D7624E88001CF0 >>> Last update of whois database: 2021-12-25T08:16:07Z <<< |